In the same trial, CHF patients with increased disease severity, based on the aforementioned criteria, were able to mobilise CD34+/CD133+/KDR+ EPCs as well as compared to the group with reduced disease severity (Kourek et al. 2020b). Here, PROM1 is linked to congestive heart failure.